Cabaletta Bio CABA Cash Flow Statement (2018-2026)

NASDAQ CABA
$3.46 -0.02 (-0.57%)
As of: Sep 4, 2026 · 3:59 PM EDT
Reported Financials

Cabaletta Bio Quarterly Cash Flow Statement

Periods 31 quarters
Latest Jun 2026

Cabaletta Bio cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 31 quarters of results from Sep 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Operating Activities
Net Income
-11.14M-11.56M-13.89M-12.95M-12.91M-11.43M-15.69M-15.85M-14.49M-16.45M-20.89M-25.05M-27.60M-30.63M-32.59M-35.94M-45.07M-45.36M-41.84M-50.93M
Share-based Compensation
15.68M15.15M1.60M6.09M15.13M13.40M8.42M7.95M27.23M26.58M3.05M9.83M57.79M54.35M5.41M49.87M47.43M38.66M3.42M35.49M
Gains from Investment Securities
0.04M0.03M0.03M0.09M0.08M
Cash from Operations
-6.58M-8.34M-10.52M-12.81M-11.53M-9.91M-12.13M-12.61M-11.89M-12.60M-16.45M-23.99M-20.79M-20.32M-23.12M-30.80M-30.43M-34.51M-35.34M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles
-0.02M-0.01M0.05M0.07M0.06M0.51M0.10M0.09M0.64M0.38M0.62M0.55M0.26M0.10M0.17M0.14M0.36M0.89M
Change in Working Capital
Change in Account Payables
0.96M-0.22M0.57M1.71M-1.87M-0.89M1.03M1.72M-1.87M1.30M0.52M1.66M-1.34M-2.01M2.70M1.59M0.59M1.07M-1.71M
Change in Accured Expenses
0.53M1.09M1.73M-3.02M1.01M0.43M0.40M-1.68M0.94M0.66M3.06M-3.48M1.55M6.45M-0.57M-3.54M5.61M2.31M3.05M
Other Working Capital Changes
-1.52M-0.61M0.73M-0.09M-0.29M0.34M-2.87M-0.57M-0.57M-0.57M-0.75M-1.25M-0.97M-1.84M0.77M-1.06M-1.06M-1.06M-1.06M
Investing Activities
Capital Expenditures
0.14M0.49M0.15M0.15M0.90M1.09M0.32M0.38M0.06M0.07M0.20M0.81M0.77M0.25M0.38M0.79M0.16M0.08M0.20M
Change in Acquisitions & Divestments
1.42M2.30M1.00M25.00M25.00M37.50M24.50M12.50M12.50M50.00M
Cash from Investing Activities
1.03M1.77M0.85M-49.91M-0.90M23.91M-0.32M24.62M-48.14M-0.07M1.14M-0.81M23.73M12.25M12.12M-0.79M-49.20M-50.08M49.80M
Financing Activities
Other financing activities
0.46M0.06M0.05M0.03M0.46M0.39M0.24M1.23M1.11M0.25M0.07M0.20M0.09M
Change in Capital Stock
Net Shares Issued and Repurchased
1.96M1.89M2.10M2.07M2.71M1.96M3.48M2.87M3.47M
Net Equity Issued and Repurchased
7.67M24.88M13.54M32.85M-0.23M93.84M-0.14M91.74M5.75M-5.75M93.56M
Misc.
Cash from Financing Activities
7.77M25.34M13.63M0.05M0.04M32.89M0.23M94.26M0.10M93.05M6.86M0.38M0.07M4.37M-0.55M93.37M-0.81M8.33M
Exchange Rate Effect
-0.02M0.01M0.03M-0.01M-0.01M
Change in Cash
2.22M18.77M3.96M-62.67M-12.38M13.99M20.44M12.24M34.23M-12.57M77.74M-17.95M3.32M-8.01M-6.65M-32.13M13.78M-85.41M22.78M
Free Cash Flow
-6.72M-8.84M-10.67M-12.96M-12.42M-11.01M-12.45M-12.99M-11.95M-12.67M-16.65M-24.80M-21.56M-20.58M-23.50M-31.59M-30.59M-34.59M-35.55M
Net Cash Flow
2.22M18.77M3.96M-62.67M-12.38M13.99M20.44M12.24M34.23M-12.57M77.74M-17.95M3.32M-8.01M-6.63M-32.14M13.75M-85.39M22.78M